Andrew Berens

Why SVB Leerink Is Bullish On Kinnate Biopharma

AstraZeneca Has Lost The Lead In Race For Coronavirus Vaccine, Says SVB Leerink

Morgan Stanley: Epizyme Has 'Blockbuster' Cancer Drug In The Making

AstraZeneca Has Lost The Lead In Race For Coronavirus Vaccine, Says SVB Leerink

Morgan Stanley: Epizyme Has 'Blockbuster' Cancer Drug In The Making

A Biotech Binary Event Playbook: How To Play Clovis And Tesaro Ahead Of Label Decision

Morgan Stanley Compares Cempra's Solithera To Ketek, Slashes Stock's Target From $35 To $5

A Biotech Binary Event Playbook: How To Play Clovis And Tesaro Ahead Of Label Decision

Morgan Stanley Compares Cempra's Solithera To Ketek, Slashes Stock's Target From $35 To $5

Can Cempra Clear Solithera Hurdle After FDA Reveal?

Intercept's Ocaliva To Experience 'Sluggish Uptake,' Investment Thesis Now 'Rapidly Shifts' To Execution In PBC

Andrew Berens Recent News

Another Wild Ride In Intercept Pharmaceuticals

Ocular Therapeutix Spikes 45% On Drug News; Morgan Stanley Upgraded Co. To Overweight

Relypsa Lost Major Ground; Feuerstein Tweets Favus Report Said 'Nothing New'

Calls Of Note: Wall Street Research Moving The Market On Thursday

Morgan Stanley: Time To Sell Rockwell Medical

Achillion Pharmaceuticals, Inc. Shares Trading At Highs Following Positive Comments From FBR Capital